Women ages 18-50 with Uterine Fibroids and/or Endometriosis can participate to reduce their signs and symptoms.
You must be premenopausal and not pregnant or planning to become pregnant in the near future. In this study you will receive Elagolix or Relugolix in combination with oral contraceptives. You will also receive applicable study visits, exams, and labs at no cost.
See if you qualify and/or send us your questions with the form below. You may also call or text us! 208-502-3039